SCHEDULE: Millennium Management Reports RxSight Stake

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 7.3% of RxSight, Inc. common stock.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G, indicating their beneficial ownership of RxSight, Inc. common stock.
• The total number of shares beneficially owned is 3,030,287, representing 7.3% of the class of securities.
• These entities share voting and dispositive power over the reported shares.
• The filing is an amendment (Amendment No. 2) to a previous filing.
• The date of the event requiring this filing is June 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without indicating new investment strategies or significant shifts in holdings.

Positives

• The filing clearly discloses a significant ownership stake (7.3%) in RxSight, Inc. by established investment entities, which can signal confidence in the company's long-term prospects.
• The joint filing agreement ensures transparency and coordinated reporting among the involved parties.

Negatives

• The filing does not provide specific details on the acquisition or disposition of these shares, nor does it offer insight into the investment strategy behind holding this stake.
• The reporting entities explicitly state that the filing should not be construed as an admission of beneficial ownership beyond their direct control.

Risks

• Potential for future changes in beneficial ownership by Millennium Management LLC, which could impact RxSight's stock price and market dynamics.
• The concentration of ownership among a few entities could influence corporate governance decisions.

Future Outlook

No specific forward-looking statements or guidance are provided in this Schedule 13G filing, as it primarily concerns ownership disclosure.

Management Comments

• The filing includes a certification stating that the securities were not acquired or held for the purpose or effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than in connection with a nomination under Rule 240.14a-11.
• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have entered into a joint filing agreement to report their beneficial ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. This filing indicates Millennium Management's continued interest in RxSight, Inc., a company operating in the medical technology sector, specifically in ophthalmic devices.

Comparison to Industry Standards

• Institutional ownership stakes of 7.3% are substantial and align with typical holdings by large investment firms in publicly traded companies within the healthcare technology sector.
• The reporting entities, Millennium Management LLC, are known for significant investments across various sectors, and this filing is consistent with their strategy of managing large portfolios.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major investment firm can influence investor sentiment and potentially impact share price.
• Management of RxSight, Inc.: The presence of a large institutional holder may lead to increased engagement on corporate governance and strategic matters.

Next Steps

• Continued monitoring of Millennium Management LLC's beneficial ownership in RxSight, Inc. for any further changes.
• Observing any potential future actions by Millennium Management LLC regarding their stake, such as further acquisitions or dispositions.

Key Dates

Keywords

RxSight, Millennium Management, Beneficial Ownership, Schedule 13G, Investment, Common Stock, Securities